219 related articles for article (PubMed ID: 20527023)
1. IGF2 over-expression in solitary fibrous tumours is independent of anatomical location and is related to loss of imprinting.
Hajdu M; Singer S; Maki RG; Schwartz GK; Keohan ML; Antonescu CR
J Pathol; 2010 Jul; 221(3):300-7. PubMed ID: 20527023
[TBL] [Abstract][Full Text] [Related]
2. Loss of CD34 and high IGF2 are associated with malignant transformation in solitary fibrous tumors.
Schulz B; Altendorf-Hofmann A; Kirchner T; Katenkamp D; Petersen I; Knösel T
Pathol Res Pract; 2014 Feb; 210(2):92-7. PubMed ID: 24360568
[TBL] [Abstract][Full Text] [Related]
3. Expanding the spectrum of malignant progression in solitary fibrous tumors: a study of 8 cases with a discrete anaplastic component--is this dedifferentiated SFT?
Mosquera JM; Fletcher CD
Am J Surg Pathol; 2009 Sep; 33(9):1314-21. PubMed ID: 19718788
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling of solitary fibrous tumors.
Bertucci F; Bouvier-Labit C; Finetti P; Metellus P; Adelaide J; Mokhtari K; Figarella-Branger D; Decouvelaere AV; Miquel C; Coindre JM; Birnbaum D
PLoS One; 2013; 8(5):e64497. PubMed ID: 23734203
[TBL] [Abstract][Full Text] [Related]
5. Patterns of deregulation of insulin growth factor signalling pathway in paediatric and adult gastrointestinal stromal tumours.
Italiano A; Chen J; Zhang L; Hajdu M; Singer S; DeMatteo RP; Antonescu CR
Eur J Cancer; 2012 Nov; 48(17):3215-22. PubMed ID: 22770876
[TBL] [Abstract][Full Text] [Related]
6. Differential diagnosis of solitary fibrous tumors: A study of 454 soft tissue tumors indicating the diagnostic value of nuclear STAT6 relocation and ALDH1 expression combined with in situ proximity ligation assay.
Ouladan S; Trautmann M; Orouji E; Hartmann W; Huss S; Büttner R; Wardelmann E
Int J Oncol; 2015; 46(6):2595-605. PubMed ID: 25901508
[TBL] [Abstract][Full Text] [Related]
7. Carcinoma of the colon and rectum with deregulation of insulin-like growth factor 2 signaling: clinical and molecular implications.
Belharazem D; Magdeburg J; Berton AK; Beissbarth L; Sauer C; Sticht C; Marx A; Hofheinz R; Post S; Kienle P; Ströbel P
J Gastroenterol; 2016 Oct; 51(10):971-84. PubMed ID: 26984550
[TBL] [Abstract][Full Text] [Related]
8. Wilms tumour histology is determined by distinct types of precursor lesions and not epigenetic changes.
Fukuzawa R; Anaka MR; Heathcott RW; McNoe LA; Morison IM; Perlman EJ; Reeve AE
J Pathol; 2008 Aug; 215(4):377-87. PubMed ID: 18484682
[TBL] [Abstract][Full Text] [Related]
9. Phenotypical and molecular distinctness of sinonasal haemangiopericytoma compared to solitary fibrous tumour of the sinonasal tract.
Agaimy A; Barthelmeß S; Geddert H; Boltze C; Moskalev EA; Koch M; Wiemann S; Hartmann A; Haller F
Histopathology; 2014 Nov; 65(5):667-73. PubMed ID: 24807787
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive methylation analysis of imprinting-associated differentially methylated regions in colorectal cancer.
Hidaka H; Higashimoto K; Aoki S; Mishima H; Hayashida C; Maeda T; Koga Y; Yatsuki H; Joh K; Noshiro H; Iwakiri R; Kawaguchi A; Yoshiura KI; Fujimoto K; Soejima H
Clin Epigenetics; 2018 Dec; 10(1):150. PubMed ID: 30509319
[TBL] [Abstract][Full Text] [Related]
11. Loss of imprinting of IGF2 in Ewing's sarcoma.
Zhan S; Shapiro DN; Helman LJ
Oncogene; 1995 Dec; 11(12):2503-7. PubMed ID: 8545106
[TBL] [Abstract][Full Text] [Related]
12. Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor.
Ravenel JD; Broman KW; Perlman EJ; Niemitz EL; Jayawardena TM; Bell DW; Haber DA; Uejima H; Feinberg AP
J Natl Cancer Inst; 2001 Nov; 93(22):1698-703. PubMed ID: 11717330
[TBL] [Abstract][Full Text] [Related]
13. IGF2 expression in blood is not associated with its imprinting status in healthy pregnant Chinese women.
Ru-Fei G; Xue-Qing L; Ying-Xiong W; Xue-Mei C; Yu-Bin D; Jun-Lin H
Biol Res; 2012; 45(4):351-6. PubMed ID: 23558990
[TBL] [Abstract][Full Text] [Related]
14. Loss of imprinting of the insulin-like growth factor II gene in renal cell carcinoma.
Nonomura N; Nishimura K; Miki T; Kanno N; Kojima Y; Yokoyama M; Okuyama A
Cancer Res; 1997 Jul; 57(13):2575-7. PubMed ID: 9205056
[TBL] [Abstract][Full Text] [Related]
15. Sunitinib malate and figitumumab in solitary fibrous tumor: patterns and molecular bases of tumor response.
Stacchiotti S; Negri T; Palassini E; Conca E; Gronchi A; Morosi C; Messina A; Pastorino U; Pierotti MA; Casali PG; Pilotti S
Mol Cancer Ther; 2010 May; 9(5):1286-97. PubMed ID: 20457621
[TBL] [Abstract][Full Text] [Related]
16. Loss of imprinting and abnormal expression of the insulin-like growth factor 2 gene in gastric cancer.
Zuo QS; Yan R; Feng DX; Zhao R; Chen C; Jiang YM; Cruz-Correa M; Casson AG; Kang XD; Han F; Chen T
Mol Carcinog; 2011 May; 50(5):390-6. PubMed ID: 21268128
[TBL] [Abstract][Full Text] [Related]
17. Loss of imprinting mutations define both distinct and overlapping roles for misexpression of IGF2 and of H19 lncRNA.
Park KS; Mitra A; Rahat B; Kim K; Pfeifer K
Nucleic Acids Res; 2017 Dec; 45(22):12766-12779. PubMed ID: 29244185
[TBL] [Abstract][Full Text] [Related]
18. High IGF2 and FGFR3 are associated with tumour progression in undifferentiated pleomorphic sarcomas, but EGFR and FGFR3 mutations are a rare event.
Rüping K; Altendorf-Hofmann A; Chen Y; Kampmann E; Gibis S; Lindner L; Katenkamp D; Petersen I; Knösel T
J Cancer Res Clin Oncol; 2014 Aug; 140(8):1315-22. PubMed ID: 24804818
[TBL] [Abstract][Full Text] [Related]
19. Loss of imprinting of IGF2 in fibroadenomas and phyllodes tumors of the breast.
Mishima C; Kagara N; Tanei T; Naoi Y; Shimoda M; Shimomura A; Shimazu K; Kim SJ; Noguchi S
Oncol Rep; 2016 Mar; 35(3):1511-8. PubMed ID: 26676988
[TBL] [Abstract][Full Text] [Related]
20. Molecular changes in solitary fibrous tumor progression.
Park HK; Yu DB; Sung M; Oh E; Kim M; Song JY; Lee MS; Jung K; Noh KW; An S; Song K; Nam DH; Kim YJ; Choi YL
J Mol Med (Berl); 2019 Oct; 97(10):1413-1425. PubMed ID: 31321477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
